Y MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial
by Raab, Marc-Steffen (Author)
, Engelhardt, Monika (Author)
, Blank, Antje (Author)
, Goldschmidt, Hartmut (Author)
, Agis, Hermine (Author)
, Blau, Igor W. (Author)
, Einsele, Hermann (Author)
, Ferstl, Barbara (Author)
, Schub, Natalie (Author)
, Röllig, Christoph (Author)
, Weisel, Katja (Author)
, Winderlich, Mark (Author)
, Griese, Janine (Author)
, Härtle, Stefan (Author)
, Weirather, Johannes (Author)
, Jarutat, Tiantom (Author)
, Peschel, Christian (Author)
, Chatterjee, Manik (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource